Multidisciplinary Approach to Optimizing Care of MDS Patients Based on Risk

HOPA recently partnered with the Advanced Practitioners Society for Hematology and Oncology (APSHO), and the Association of Community Cancer Centers (ACCC) on a collaborative effort to identify and address practice gaps in the treatment of anemia in adults with myelodysplastic syndromes (MDS).

Two HOPA members served on a multi-disciplinary advisory committee and participated in video podcasts.

Webinar 1: Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML

  • HOPA Pesenter: Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, Clinical Oncology Pharmacy Manager, Atrium Health Levine Cancer in Charlotte, North Carolina
  • Watch the Video Podcast (11:39 run time)

Webinar 2: Defining and Managing Erythropoietin Stimulating Agents (ESAs) Failure in Patients with Low-Risk MDS

  • HOPA Presenter: Steven Gilmore, PharmD, BCOP, Senior Manager, Clinical Content, Pharmacy & Clinical Programs, McKesson Specialty Health in Baltimore, Maryland 
  • Watch the Video Podcast (9:12 run time)

Webinar 3: Addressing Frequency of Care to Improve Quality of Life in Patients with Low Risk Anemia